Cargando…
DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis
Dipeptidyl peptidase IV (DPPIV), also known as CD26, is a 110-kDa cell surface glycoprotein expressed in various tissues. DPPIV reportedly plays a direct role in the progression of several human malignancies. DPPIV specific inhibitors are employed as antidiabetics and could potentially be repurposed...
Autores principales: | Yang, Xiaoqing, Zhang, Xinhua, Wu, Rongrong, Huang, Qicheng, Jiang, Yao, Qin, Jianbing, Yao, Feng, Jin, Guohua, Zhang, Yuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352432/ https://www.ncbi.nlm.nih.gov/pubmed/28060721 http://dx.doi.org/10.18632/oncotarget.14412 |
Ejemplares similares
-
P4HA2 promotes cell proliferation and migration in glioblastoma
por: Wu, Yuying, et al.
Publicado: (2021) -
Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells
por: Beckenkamp, Aline, et al.
Publicado: (2015) -
Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo
por: Matić, Ivana Z, et al.
Publicado: (2012) -
Expression of EZH2 in endometrial carcinoma and its effects on proliferation and invasion of endometrial carcinoma cells
por: Gu, Yuting, et al.
Publicado: (2017) -
Improved glucose tolerance with DPPIV inhibition requires β‐cell SENP1 amplification of glucose‐stimulated insulin secretion
por: Ferdaoussi, Mourad, et al.
Publicado: (2020)